• SENSEX 74,660.02
    -121.74 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Solar Industries
    19,450.15 11,641.10(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • TCS
    2,322.50 3,336.70(%)
  • Pine Labs
    191.50 134.75(%)
  • Reliance Industries
    1,249.00 1,250.55(%)
  • Netweb Technol.
    4,682.85 2,820.80(%)
  • Gland Pharma
    2,882.00 1,575.00(%)
  • Bharat Electron
    387.65 380.35(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Coforge
    1,784.00 1,008.50(%)
  • SBI
    979.80 816.25(%)
  • IFCI
    78.12 46.20(%)
  • Piramal Finance.
    2,236.40 1,235.15(%)
  • Dhoot Transmission
    1,554.65 1,130.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bacil Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3688.0
  • ISIN : INE711D01018
19.38 1 (4.98%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    18.83

  • Today’s High

    19.38

  • Open

    19.24

  • Perv Close

    18.46

  • 52W Low

    10.65

  • 52W High

    61.80

Key Indicators

  • P/E(TTM)

    42.13

  • Mar.Cap (₹Cr.)

    27.82

  • Div & Yield %

    0.00

  • Book Value(₹)

    17.55

  • Debt-Equity Ratio

    4.98

  • AGM Date

    11-Sep-2026

  • EPS

    0.46

  • P/E Ratio

    42.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    27.82

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.35

  • BV (₹)

    17.60

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    1.56

  • NP Var(%)

    1231.0

  • Div%

    0.0

  • CPS (₹)

    1.10

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    27.82

  • 52 Week High

    61.80

  • 52 Week Low

    10.65

  • Price BSE

    19.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    27.82

  • P/C Ratio

    17.50

  • P/E Ratio

    17.50

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 1.24 0.66 0.13 0.11 0.06 0.07
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1.24 0.66 0.13 0.11 0.06 0.07
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.05 0.14 0.10 0.09 0.06 0.05
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.14 0.11 0.08 0.08 0.09 0.08
Miscellaneous Expenses 0.05 0.00 0.00 0.05 3.76 0.17
Employee Benefit Expenses 0.05 0.14 0.10 0.09 0.06 0.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.25 0.25 0.19 0.21 3.91 0.30
Operating Profit 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.57 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 1.56 0.40 -0.06 -0.10 -3.86 -0.24
Extraordinary Items 0.00 0.54 0.10 0.05 -3.76 -0.14
Adjusted Net Profit 1.56 -0.14 -0.16 -0.15 -0.10 -0.10
Adjustment below Net Profit -2.17 16.37 0.17 -0.02 3.69 0.24
P & L Balance brought forward 11.46 -5.31 -5.43 -5.30 -5.14 -5.14
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 10.84 11.46 -5.31 -5.43 -5.30 -5.14
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.11 0.29 -0.09 -0.16 -5.91 -0.37
Earnings Per Share(Adj)-Unit Curr 1.11 0.29 -0.09 -0.16 -5.91 -0.37
Book Value 17.76 18.20 1.86 1.68 1.88 2.13
Book Value(Adj)-Unit Curr 17.76 18.20 1.86 1.68 1.88 2.13

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 302,147 2.11 302,147 19
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 86,742 0.60 86,742 112
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 218,329 1.52 218,329 30
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,733,561 74.78 10,659,561 43
Individuals holding nominal share capital up to Rs. 1 lakh 3,012,021 20.99 1,122,821 7,121
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 200 0.00 200 1
Others 0 0.00 0 0
Sub Total 14,353,000 100.00 12,389,800 7,326
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 14,353,000 100.00 12,389,800 7,326

Company Background

Bacil Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Bacil Pharma Ltd
  • BSE Code : 3688.0
  • ISIN : INE711D01018

  • Incorporation Year

    1987

  • Registered Office

    G2 & G3 Samarpan Complex
    chakala Andheri East, Mumbai,
    Maharashtra-400099

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Tak Bhavana Tak

  • Auditor

    Laxmikant Kabra & Co LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Bacil Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bacil Pharma 19.38 1.24 0.00 42.13 3.93
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77